tirzepatide get Treatment Tirzepatide for Weight Loss |

This article is for general information only and isnt a substitute for medical advice

To put this into context, Ozempic was first approved (for diabetes) in 2017

Risk factors include female gender, increased age, cardiovascular disease, diabetes mellitus, constipation, irritable bowel syndrome, thrombophilia, history of abdominal aortic aneurysm repair, constipation-inducing drugs, immunomodulators, and other illicit drug use [1,2,3]

Questions Worth Asking Before and During GLP-1 Treatment If you are considering a GLP-1 medication, or if you are already taking one and wondering whether your emotional experience deserves more attention, these questions are worth sitting with: Have you ever experienced restricting, binge eating, purging, or significant preoccupation with food, weight, or your body, even if it was never formally diagnosed

The combination also reflects the breadth of supporting literature